Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation

COLUMBIA, S.C. (April 30, 2021) – Ritedose, a 503B outsourcing facility located in South Carolina, just launched a new unit dose syringe product, Labetalol Hydrochloride Injection 20 mg/4 mL (5mg/mL). It is part of a 12-product, six-month rollout from Ritedose for hospital pharmacies across the coun

Pfizer 00409226720 - McKesson Medical-Surgical

00409-4264-01 Pfizer Hospital US

2021 – The Ritedose Corporation

Ritedose Sodium Chloride for Inhalation 7% is a sterile, aqueous solution of sodium chloride for inhalation. The solution is used to help loosen and

Ritedose Sodium Chloride for Inhalation 7% Unit Dose 4 mL Ampule Vials

Cardinal 8881570300 - McKesson Medical-Surgical

Ritedose Launches New Single-Dose Syringe Product: Labetalol

News – The Ritedose Corporation

Hospira 00409379501 - McKesson Medical-Surgical

Press Releases – The Ritedose Corporation